ATE61223T1 - Therapeutische verwendung von cyproteronacetat. - Google Patents

Therapeutische verwendung von cyproteronacetat.

Info

Publication number: ATE61223T1
Authority: AT; Austria
Prior art keywords: therapeutic use; cyproterone acetate; estrogen; iperestrogenism; intrafollicular
Prior art date: 1985-01-08

Application number

AT85111963T

Other languages

English (en)

Inventor

Manlio Blandamura

Original Assignee

Finchimica Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-08

Filing date

1985-09-20

Publication date

1991-03-15

1985-09-20 Application filed by Finchimica Srl filed Critical Finchimica Srl

1991-03-15 Application granted granted Critical

1991-03-15 Publication of ATE61223T1 publication Critical patent/ATE61223T1/de

Links

229960000978 cyproterone acetate Drugs 0.000 title abstract 2
UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
230000000903 blocking effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
230000001173 tumoral effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

AT85111963T 1985-01-08 1985-09-20 Therapeutische verwendung von cyproteronacetat. ATE61223T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT19041/85A IT1199625B (it)	1985-01-08	1985-01-08	Uso terapeutico del ciproterone acetato
EP85111963A EP0187200B1 (de)	1985-01-08	1985-09-20	Therapeutische Verwendung von Cyproteronacetat

Publications (1)

Publication Number	Publication Date
ATE61223T1 true ATE61223T1 (de)	1991-03-15

Family

ID=11154048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85111963T ATE61223T1 (de)	1985-01-08	1985-09-20	Therapeutische verwendung von cyproteronacetat.

Country Status (6)

Country	Link
US (1)	US4639440A (de)
EP (1)	EP0187200B1 (de)
JP (1)	JPS61161218A (de)
AT (1)	ATE61223T1 (de)
DE (1)	DE3582044D1 (de)
IT (1)	IT1199625B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3936328A1 (de) *	1989-10-27	1991-05-02	Schering Ag	Pharmazeutische praeparate
US11376263B2 (en)	2020-10-08	2022-07-05	Fortress Biotech, Inc.	Cyproterone acetate compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1570524A (en) *	1976-03-11	1980-07-02	Unilever Ltd	Cosmetic
IT1149935B (it) *	1980-07-02	1986-12-10	Finchimica Srl	Uso farmacologico del 6-cloro-17-idrossi 1 alfa,2 alfa-metilpregna 4,6-dien-3,20-dione

1985
- 1985-01-08 IT IT19041/85A patent/IT1199625B/it active
- 1985-09-20 EP EP85111963A patent/EP0187200B1/de not_active Expired - Lifetime
- 1985-09-20 AT AT85111963T patent/ATE61223T1/de not_active IP Right Cessation
- 1985-09-20 DE DE8585111963T patent/DE3582044D1/de not_active Expired - Fee Related
- 1985-09-24 US US06/779,421 patent/US4639440A/en not_active Expired - Lifetime
- 1985-12-16 JP JP60281280A patent/JPS61161218A/ja active Granted

Also Published As

Publication number	Publication date
DE3582044D1 (de)	1991-04-11
EP0187200A2 (de)	1986-07-16
EP0187200B1 (de)	1991-03-06
IT1199625B (it)	1988-12-30
US4639440A (en)	1987-01-27
IT8519041A0 (it)	1985-01-08
JPH0443884B2 (de)	1992-07-20
EP0187200A3 (en)	1989-02-22
JPS61161218A (ja)	1986-07-21
IT8519041A1 (it)	1986-07-08

Similar Documents

Publication	Publication Date	Title
BG60253B1 (bg)	1994-03-24	Човешки тъканен плазминогенен активатор
ES2032770T3 (es)	1993-03-01	Un procedimiento para producir farmacos de administracion nasal.
DK155389A (da)	1989-10-01	Praeparater indeholdende thymol, herunder mundhygiejnepraeparater, til maskering af smagen af thymol
IT1086778B (it)	1985-05-31	Disposizione di assistenza per pazienti sofferenti di incontinenza
SE7701662L (sv)	1977-10-20	Patientstol, serskilt tandlekarstol
ATE367816T1 (de)	2007-08-15	Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten
DE3588023D1 (de)	1995-06-29	Mittel zur Behandlung von Herzerkrankungen.
NO862096L (no)	1986-12-01	Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
Newman et al.	1937	Sulfanilamide: a photosensitizing agent of the skin
ATE193442T1 (de)	2000-06-15	3,4-diarylchromane zur behandlung von dermatitis
NO912435D0 (no)	1991-06-21	Farmasoeytiske preparater.
DE59605959D1 (de)	2000-11-09	Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
JPS5218813A (en)	1977-02-12	Plasters for the relief of cutaneous diseases
ATE220912T1 (de)	2002-08-15	Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
DE3582044D1 (de)	1991-04-11	Therapeutische verwendung von cyproteronacetat.
BE867396A (fr)	1978-11-24	Nouveau medicament utile dans le traitement des affections bacteriennes
KR100271087B1 (en)	2000-11-01	Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
EP0254593A3 (de)	1989-09-27	Herstellung und Verwendungen von gamma-Interferon
DE3751597D1 (de)	1995-12-21	Verwendung von 15-Deoxyspergualin als Arzneimittel.
FI74003B (fi)	1987-08-31	Foerfarande foer framstaellning av en terapeutiskt anvaendbar 5,14-dihydrobens/5,6/isoindolo/2,1-b/isokinolin- 8,13-dion.
FR2521006B1 (fr)	1986-09-12	Nouveau medicament compose utile notamment pour le traitement des maladies infectieuses
RU97115801A (ru)	1999-06-27	Способ лечения стенозирующих ларинготрахеитов у детей
BE860239A (fr)	1978-04-28	Preparation medicinale pour le traitement des neoformations malignes
DK0859630T3 (da)	2003-03-24	Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
IT8321398A0 (it)	1983-06-01	Preparazioni farmaceutiche per trattamento topico della cataratta.

Legal Events

Date	Code	Title	Description
1991-10-15	UEP	Publication of translation of european patent specification
1999-06-15	REN	Ceased due to non-payment of the annual fee